Lymph node-induced immune tolerance in chronic lymphocytic leukaemia: a role for caveolin-1
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lymph node-induced immune tolerance in chronic lymphocytic leukaemia: a role for caveolin-1
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 158, Issue 2, Pages 216-231
Publisher
Wiley
Online
2012-05-10
DOI
10.1111/j.1365-2141.2012.09148.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Wiskott-Aldrich Syndrome: The Actin Cytoskeleton and Immune Cell Function
- (2013) Michael P. Blundell et al. DISEASE MARKERS
- Biomechanical Remodeling of the Microenvironment by Stromal Caveolin-1 Favors Tumor Invasion and Metastasis
- (2011) Jacky G. Goetz et al. CELL
- Involvement of Protein Kinase C and RhoA in Protease-Activated Receptor 1–Mediated F-Actin Reorganization and Cell Growth in Rat Cardiomyocytes
- (2011) Hitomi Otani et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- The Ras Inhibitors Caveolin-1 and Docking Protein 1 Activate Peroxisome Proliferator-Activated Receptor through Spatial Relocalization at Helix 7 of Its Ligand-Binding Domain
- (2011) E. Burgermeister et al. MOLECULAR AND CELLULAR BIOLOGY
- The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk
- (2011) E Arpaia et al. ONCOGENE
- Intraflagellar transport: a new player at the immune synapse
- (2011) Francesca Finetti et al. TRENDS IN IMMUNOLOGY
- An overview of chronic lymphocytic leukaemia biology
- (2010) M.T.S. Bertilaccio et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- HS1 has a central role in the trafficking and homing of leukemic B cells
- (2010) C. Scielzo et al. BLOOD
- CAV1 Inhibits Metastatic Potential in Melanomas through Suppression of the Integrin/Src/FAK Signaling Pathway
- (2010) C. Trimmer et al. CANCER RESEARCH
- Biological diversity and risk-adapted treatment of chronic lymphocytic leukemia
- (2010) T. Zenz et al. HAEMATOLOGICA
- Focal-adhesion targeting links caveolin-1 to a Rac1-degradation pathway
- (2010) M. Nethe et al. JOURNAL OF CELL SCIENCE
- How the microenvironment shapes chronic lymphocytic leukemia: the cytoskeleton connection
- (2010) Cristina Scielzo et al. LEUKEMIA & LYMPHOMA
- RhoA Regulates Peroxisome Association to Microtubules and the Actin Cytoskeleton
- (2010) Lukas Schollenberger et al. PLoS One
- Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): From understanding the basics towards therapeutic targeting
- (2010) Jan A. Burger SEMINARS IN CANCER BIOLOGY
- Caveolin-1−/− Null Mammary Stromal Fibroblasts Share Characteristics with Human Breast Cancer-Associated Fibroblasts
- (2009) Federica Sotgia et al. AMERICAN JOURNAL OF PATHOLOGY
- An Absence of Stromal Caveolin-1 Expression Predicts Early Tumor Recurrence and Poor Clinical Outcome in Human Breast Cancers
- (2009) Agnieszka K. Witkiewicz et al. AMERICAN JOURNAL OF PATHOLOGY
- Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach
- (2009) M. Niedermeier et al. BLOOD
- B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406
- (2009) M. P. Quiroga et al. BLOOD
- Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma
- (2009) J. Iqbal et al. BLOOD
- Increased PEA3/E1AF and decreased Net/Elk-3, both ETS proteins, characterize human NSCLC progression and regulate caveolin-1 transcription in Calu-1 and NCI-H23 NSCLC cell lines
- (2009) Karin A. Sloan et al. CARCINOGENESIS
- Chronic lymphocytic leukemia microenvironment: shifting the balance from apoptosis to proliferation
- (2009) S. Deaglio et al. HAEMATOLOGICA
- Expansion of regulatory T cells in B chronic lymphocytic leukemia: enhanced ‘brakes’ on host immunity
- (2009) Varda Deutsch et al. LEUKEMIA & LYMPHOMA
- Enhanced formation and survival of CD4+CD25hiFoxp3+T-cells in chronic lymphocytic leukemia
- (2009) Margot Jak et al. LEUKEMIA & LYMPHOMA
- Molecular and cellular mechanisms of CLL: novel therapeutic approaches
- (2009) Lisa Pleyer et al. Nature Reviews Clinical Oncology
- E -TCL1 mice represent a model for immunotherapeutic reversal of chronic lymphocytic leukemia-induced T-cell dysfunction
- (2009) G. Gorgun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation
- (2008) J. A. Burger et al. BLOOD
- Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies
- (2008) Farbod Shojaei et al. DRUG RESISTANCE UPDATES
- Molecular characterisation of the tumour microenvironment in breast cancer
- (2008) Min Hu et al. EUROPEAN JOURNAL OF CANCER
- Adaptive Foxp3+ Regulatory T Cell-Dependent and -Independent Control of Allergic Inflammation
- (2008) Maria A. Curotto de Lafaille et al. IMMUNITY
- Concerted regulation of focal adhesion dynamics by galectin-3 and tyrosine-phosphorylated caveolin-1
- (2008) Jacky G. Goetz et al. JOURNAL OF CELL BIOLOGY
- Hedgehog-Induced Survival of B-Cell Chronic Lymphocytic Leukemia Cells in a Stromal Cell Microenvironment: A Potential New Therapeutic Target
- (2008) G. V. Hegde et al. MOLECULAR CANCER RESEARCH
- Co-evolution of tumor cells and their microenvironment
- (2008) Kornelia Polyak et al. TRENDS IN GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More